<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Selective IgM deficiency</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Selective IgM deficiency</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Selective IgM deficiency</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Guha Krishnaswamy, MD, FACP, FCCP, FACAAI, FAAAI, CC-D</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Luigi D Notarangelo, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anna M Feldweg, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 01, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Selective immunoglobulin M deficiency (sIgMD) is a rare immune disorder that has been reported in association with serious infections, such as bacteremia. The disorder can occur in infants, children, and adults. Cumulatively, there have been fewer than 300 cases reported in the literature, and understanding of this condition is therefore preliminary. This topic review discusses the normal immunophysiology of immunoglobulin M (IgM), theories of pathogenesis, and the clinical features, diagnosis, and treatment of sIgMD. More general discussions of antibody deficiency are found separately. (See  <a class="medical medical_review" href="/z/d/html/3914.html" rel="external">"Primary humoral immunodeficiencies: An overview"</a>.)</p><p class="headingAnchor" id="H6106648"><span class="h1">DEFINITION</span><span class="headingEndMark"> — </span>sIgMD is characterized by the following clinical and laboratory features:</p><p class="bulletIndent1"><span class="glyph">●</span>Isolated absence or deficiency of IgM</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>No other identifiable immunodeficiency or external cause of low serum IgM</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Normal levels of immunoglobulin G (IgG) and immunoglobulin A (IgA)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Recurrent infections in the majority of patients, with susceptibility to <em>Staphylococcus aureus</em>, encapsulated pathogens (<em>Streptococcus pneumoniae</em>, <em>Haemophilus influenzae</em>), and viral infections  </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Normal T cell numbers and function in most patients, although occasional variations are reported </p><p></p><p>The <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fesid.org%2F&amp;token=aegwOiTzo8fRSk7pW0vv46Cf5DrxR8puHePi1Q6sMYg%3D&amp;TOPIC_ID=3921" target="_blank">European Society for Immunodeficiencies</a> (ESID) registry has <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fesid.org%2FWorking-Parties%2FRegistry-Working-Party%2FDiagnosis-criteria&amp;token=SO9lgnozSbNXA8sH1%2B5YIv2eQXbaSTJj2b467ZfT3cjxSEavsz1P6oDPLWE%2BQczN%2BREI8xs5UsSEOX6jXFxr5biTMVJ%2FeOqY2T4R4jvtmjE%3D&amp;TOPIC_ID=3921" target="_blank">defined primary sIgMD</a> as a decreased serum IgM level (repeatedly ≥2 standard deviations [SD] below the mean for age) with normal levels of serum IgA, IgG and IgG subclasses, normal vaccination responses, absence of T cell defects, and absence of causative external factors. However, aspects of this definition are unclear [<a href="#rid1">1</a>]. Specifically, consensus is lacking about whether IgG subclasses and vaccination responses must be normal to make the diagnosis, and if the presence of any defect in T cell number or function excludes the diagnosis. </p><p class="headingAnchor" id="H2"><span class="h1">NORMAL IMMUNOPHYSIOLOGY OF IgM</span><span class="headingEndMark"> — </span>The five classes or isotypes of immunoglobulins that contribute to humoral immunity are IgG, IgM, IgA, immunoglobulin D (IgD), and immunoglobulin E (IgE). (See  <a class="medical medical_review" href="/z/d/html/3971.html" rel="external">"Structure of immunoglobulins"</a>.)</p><p>Naïve B lymphocytes express both IgM and IgD, and these are the only immunoglobulin isotypes produced by B lymphocytes prior to contact with antigen. Membrane-bound monomeric IgM, complexed with additional proteins, such as Ig-alpha and Ig-beta, constitute the B cell receptor for antigen. Naïve B lymphocytes use alternative messenger RNA splicing to make both IgM and IgD. The mu and delta constant region (C) genes, which code for the M and D heavy chains, respectively, are those nearest to the assembled VDJ sequence  (<a class="graphic graphic_figure graphicRef75596" href="/z/d/graphic/75596.html" rel="external">figure 1</a>).</p><p>Following binding of antigen by the B lymphocyte receptor, signaling occurs through immunoreceptor tyrosine-based activation motifs, leading to activation of intracellular pathways, which ultimately culminate in changes in B lymphocyte gene expression. In the presence of appropriate activation (costimulators, cytokines, etc), B lymphocytes rearrange their immunoglobulin heavy chain constant genes to switch from IgM to IgG, IgA, or IgE  (<a class="graphic graphic_figure graphicRef77742" href="/z/d/graphic/77742.html" rel="external">figure 2</a>) [<a href="#rid2">2,3</a>]. Immunoglobulin gene rearrangement is presented in more detail separately. (See  <a class="medical medical_review" href="/z/d/html/3977.html" rel="external">"Immunoglobulin genetics"</a>.)</p><p>Secreted IgM exists as a pentamer and has a half-life of about 10 days  (<a class="graphic graphic_figure graphicRef79613" href="/z/d/graphic/79613.html" rel="external">figure 3</a>). Because of its pentameric structure, IgM is referred to as "macroglobulin." Pentameric IgM, which has 10 antigen-binding sites, readily forms antigen-antibody complexes and has high avidity, despite the fact that each individual binding site has relatively low affinity for antigen. Because of this, IgM is an exceptionally potent activator of the classical complement pathway. IgM does not activate the alternative pathway of complement, nor does it undergo transplacental transfer. The majority of IgM is intravascular in location, and accordingly, sIgMD is often associated with systemic infections and bacteremia.</p><p>The majority of natural antibodies (ie, immunoglobulins that react with multiple endogenous or exogenous antigens without prior antigenic stimulation) and autoantibodies are of the IgM class. Natural antibodies are polyspecific and of low affinity and appear to play an important role in removal of self-antigens and clearing of dead cells (housekeeping), homeostasis, and protection against microbes (especially microbes with polysaccharide components) [<a href="#rid4">4-6</a>]. IgM may regulate the selection of B lymphocyte subsets [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/z/d/html/13572.html" rel="external">"An overview of the innate immune system", section on 'Homeostasis in the innate immune system'</a>.)</p><p>IgM is the first antibody to be produced during an immune response, and most of the primary humoral immune response is mediated by IgM. The IgM response wanes as other subtypes are produced. Examples of specific disorders in which IgM responses are used in diagnosis include isohemagglutinins (which are mostly IgM but also IgG), cold agglutinins, rheumatoid factor, and the heterophile antibody [<a href="#rid8">8</a>]. </p><p class="headingAnchor" id="H3"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>The normal concentration of IgM in the serum of adults is approximately 37 to 286 mg/dL [<a href="#rid9">9</a>]. By definition, this range includes 95 percent of the population, and 2.5 percent will fall below that range. However, some of these individuals will have low levels of other immunoglobulins, in addition to IgM. Estimates of the prevalence of <strong>isolated</strong> low serum IgM levels depend upon the population examined:</p><p class="bulletIndent1"><span class="glyph">●</span>Isolated low levels of IgM in the general population were identified in one person in a study of approximately 3000 individuals [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a series of hospitalized patients, prevalence ranged from 0.1 to 2 percent [<a href="#rid11">11,12</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a study of approximately 14,000 adults being treated in an allergy and immunology practice, 36 individuals were identified, for a prevalence of approximately 1:385 in this selected population [<a href="#rid13">13</a>].</p><p></p><p>The European Society for Immunodeficiencies (ESID) reported on a multicenter study of sIgMD, in which 15 centers identified 98 patients [<a href="#rid14">14</a>]. Patients were excluded under three circumstances: if serum IgM was only determined once (n = 14), had normalized (n = 8), or if they also had other immunological abnormalities (n = 15). Only 10 patients completely fulfilled the ESID criteria for sIgMD and further, using the ESID diagnostic protocol reference values, only six patients were determined to have "true" sIgMD. Symptomatic adults had lower serum IgM levels (mean 0.27 g/L, 95% CI 0.22-0.31) than those without symptoms (mean 0.33 g/L, 95% CI 0.30-0.36).</p><p>There have been a small number of familial cases of sIgMD reported [<a href="#rid15">15-18</a>].</p><p class="headingAnchor" id="H4"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>Patients with sIgMD may by asymptomatic or they may present with repeated infections or with an associated allergic, malignant, or autoimmune condition [<a href="#rid16">16,19-23</a>]. Clinical presentations of symptomatic IgM deficiency that have been reported in the published literature are summarized in the table  (<a class="graphic graphic_table graphicRef67168" href="/z/d/graphic/67168.html" rel="external">table 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>In one study of 89 hospitalized patients, associated conditions included infections (60 percent), septicemia (36 percent), atopy (22 percent), splenomegaly (11 percent), neoplasia (7 percent), and autoimmunity (3 percent) [<a href="#rid12">12</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the series of 36 adult patients evaluated in an allergy/immunology clinic, patients presented with recurrent upper respiratory tract infections (77 percent), allergic and nonallergic rhinitis (49 percent), asthma (47 percent), angioedema (14 percent), and anaphylaxis (11 percent) [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a series of 33 children presenting to immunology clinics, 24 percent were asymptomatic and 45 percent had upper and lower respiratory tract and skin infections [<a href="#rid19">19</a>]. Autoimmune disorders were present in 18 percent, 15 percent had allergic disorders and 15 percent developed malignancies. </p><p></p><p class="headingAnchor" id="H5"><span class="h2">Repeated infections</span><span class="headingEndMark"> — </span>Based on the available studies, between 60 and 80 percent of patients with sIgMD suffer from repeated infections with both bacterial and viral pathogens. More common presentations include recurrent otitis media, bronchitis, chronic rhinosinusitis, pneumonia, and sepsis  (<a class="graphic graphic_table graphicRef68510" href="/z/d/graphic/68510.html" rel="external">table 2</a>) [<a href="#rid13">13,23-25</a>]. Failure to thrive, stunted growth, and malnutrition may be observed in severely affected children with persistent infection. There have been case reports of meningococcal septicemia, pseudomonas nasopharyngitis, recurrent staphylococcal skin infections or pyoderma, recurrent hordeola, bronchiectasis, <em>Brucella</em> infection, and polyarticular septic arthritis [<a href="#rid13">13,15,16,26-31</a>].</p><p>Viral infections reported in patients with sIgMD include occupationally acquired smallpox, generalized nonprogressive vaccinia, disseminated molluscum contagiosum, and epidermodysplasia verruciformis [<a href="#rid32">32-36</a>]. Case reports suggest that some patients with sIgMD might also be susceptible to histoplasmosis and disseminated cutaneous (avium intracellulare) or systemic (miliary tuberculosis) mycobacterial infection, although in one of the reports, an associated T cell defect was also present [<a href="#rid37">37-39</a>].</p><p class="headingAnchor" id="H6"><span class="h2">Associated conditions</span><span class="headingEndMark"> — </span>Subnormal levels of IgM may be identified in the context of another disease process  (<a class="graphic graphic_table graphicRef68510" href="/z/d/graphic/68510.html" rel="external">table 2</a>). In this setting, IgM deficiency is usually less profound and may reverse with improvement of underlying disease, although this is not noted in all reports.</p><p class="headingAnchor" id="H7"><span class="h3">Malignant and hematologic disorders</span><span class="headingEndMark"> — </span>Malignancies and hematologic diseases that have been reported in association with IgM deficiency include multiple myeloma and paraproteinemias, clear cell sarcoma, Bloom syndrome, lymphomatoid papulosis, immune thrombocytopenia (ITP), and lymphocytic leukemias [<a href="#rid28">28,40-46</a>]. One patient had acquired C1 inhibitor deficiency and later developed a B cell lymphoma [<a href="#rid26">26</a>]. (See  <a class="medical medical_review" href="/z/d/html/8112.html" rel="external">"Acquired C1 inhibitor deficiency: Clinical manifestations, epidemiology, pathogenesis, and diagnosis"</a>.)</p><p>sIgMD associated with elevated levels of serum IgA and IgG were described in one patient with hepatocellular carcinoma and autoimmune liver disease with resultant cirrhosis [<a href="#rid47">47</a>]. The relationship of IgM deficiency to hepatic malignancy is unclear.</p><p>Many immunodeficiency disorders demonstrate an increased prevalence of malignancy. This may result from dysregulation of immune surveillance, infection with transforming viruses, or other poorly defined mechanisms.</p><p class="headingAnchor" id="H8"><span class="h3">Autoimmune disorders</span><span class="headingEndMark"> — </span>Rheumatologic and autoimmune disorders are reported in association with sIgMD, although the cause and effect relationship is unclear [<a href="#rid26">26</a>]. It is also unknown whether sIgMD includes deficiency of natural antibodies/autoantibodies, which could predispose to pathologic autoantibody formation [<a href="#rid4">4,5</a>]. (See <a class="local">'Normal immunophysiology of IgM'</a> above.)</p><p>Associated disorders include systemic lupus erythematosus [<a href="#rid25">25,48-50</a>], Hashimoto's thyroiditis [<a href="#rid51">51</a>], ITP [<a href="#rid28">28</a>], autoimmune glomerulonephritis [<a href="#rid52">52</a>], autoimmune hepatitis [<a href="#rid53">53</a>], and adult-onset Still's disease [<a href="#rid54">54</a>]. In one review of the literature, 14 percent of individuals with sIgMD originally presented with autoimmune diseases [<a href="#rid13">13</a>]. In the series of 36 patients with sIgMD followed in an outpatient allergy/immunology clinic, 13 percent had low titers of antinuclear antibodies of uncertain clinical significance [<a href="#rid13">13</a>]. Whether this predicts the future development of autoimmune disorders is unknown.</p><p class="headingAnchor" id="H9"><span class="h3">Atopy</span><span class="headingEndMark"> — </span>It is likely that an increased incidence of atopy occurs in these individuals, as has been described with IgA deficiency. Allergic rhinitis, asthma, and eczema may be presenting disorders in some patients [<a href="#rid13">13,23</a>]. Allergic disease may also represent the effects of immune dysregulation.</p><p>A high prevalence of idiopathic anaphylaxis and idiopathic angioedema was noted in the series of 36 outpatients gathered from an allergy/immunology practice [<a href="#rid13">13</a>]. This is a newly proposed association that has not been observed in earlier reported cases.</p><p class="headingAnchor" id="H10"><span class="h3">Miscellaneous conditions</span><span class="headingEndMark"> — </span>Other conditions that have been described in association with sIgMD include Crohn disease, adult-onset Still's disease, gastroesophageal reflux disease, interstitial lung disease, massive splenomegaly, inflammatory multifocal osteomyelitis, and inability to train in athletes [<a href="#rid13">13,54-59</a>].</p><p>IgM deficiency may also be found in celiac disease, although it may be secondary to intestinal malabsorption in this setting, as IgM levels sometimes rise with a gluten-free diet [<a href="#rid13">13,60-64</a>].</p><p class="headingAnchor" id="H11"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Isolated IgM deficiency has been associated with serious bacterial infection and the other complications listed earlier, although it is unlikely that low or absent serum IgM, by itself, leads to increased susceptibility to infection. Rather, sIgMD is probably a manifestation of immune dysregulation, and the associated immunologic dysfunction (such as poor antibody response or other defects described below) is what results in increased infections.</p><p>The pathogenesis of sIgMD is unclear, although several mechanisms have been proposed, including B cell defects, disordered T cell help, and possibly, chromosomal defects. There are likely multiple mechanisms that can result in isolated low serum IgM:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>B lymphocyte defects</strong> – Studies have consistently found that surface levels of IgM on circulating B lymphocytes are normal in patients with sIgMD [<a href="#rid11">11,65,66</a>]. Single studies have shown normal production of messenger RNA for IgM and a lack of mutations in the mu heavy chain gene [<a href="#rid50">50,67</a>], although possible defects in IgM production by B cells were identified in other studies [<a href="#rid50">50,66</a>]. Another study showed lower numbers of nonswitched (IgM+CD27+IgD+) memory B cells in patients with sIgMD, suggesting that maturation defects of B lymphocytes might play a role in some individuals [<a href="#rid68">68</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>T lymphocyte dysfunction</strong> – Although no well-defined T cell abnormalities have been consistently identified, inadequate T cell help, excessive T cell suppressive activity, abnormal CD4/CD8 ratios, and inhibitory factors have all been demonstrated in some patients with sIgMD [<a href="#rid11">11,30,65,69,70</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chromosomal disorders</strong> – In a small number of case reports, sIgMD has been identified in patients with chromosome 22q11.2 deletion syndrome, although chromosome 22q11.2 deletions are relatively common, occurring in approximately 1 in 4000 to 6000 live births [<a href="#rid71">71,72</a>]. (See  <a class="medical medical_review" href="/z/d/html/3905.html" rel="external">"DiGeorge (22q11.2 deletion) syndrome: Epidemiology and pathogenesis"</a>.)</p><p></p><p class="headingAnchor" id="H18"><span class="h1">EVALUATION AND DIAGNOSIS</span><span class="headingEndMark"> — </span>sIgMD is usually identified when evaluating a patient for recurrent or serious infections. It is a diagnosis of exclusion, and formal diagnostic criteria have not been established. The minimal diagnostic evaluation required for the diagnosis includes the demonstration of an isolated deficiency of serum IgM and no other classifiable immunodeficiency or secondary cause of low IgM. Characteristic laboratory findings are described in the table and discussed in this section  (<a class="graphic graphic_table graphicRef80591" href="/z/d/graphic/80591.html" rel="external">table 3</a>). The clinical history should be explored for the presence of associated conditions, as these may ultimately explain the low levels of IgM. (See <a class="local">'Associated conditions'</a> above.)</p><p class="headingAnchor" id="H19"><span class="h2">Initial immunologic testing</span><span class="headingEndMark"> — </span>Any individual with recurrent infections, especially those with sepsis or other serious sequelae of infection, should be evaluated for immunodeficiency. Initial tests to evaluate for immunodeficiency include:</p><p class="bulletIndent1"><span class="glyph">●</span>Complete blood count with differential to look for abnormally high or low cell populations and low platelets (see <a class="local">'Malignant and hematologic disorders'</a> above)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Quantitative serum immunoglobulin levels (IgG, IgM, IgA, and IgE)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A measure of total hemolytic complement (CH50) to screen for complement deficiency</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Testing for HIV if the patient has any risk factors</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Flow cytometric lymphocyte analysis to quantitate B cells, T cells, and natural killer cells</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Antinuclear antibodies as an initial screen for autoimmunity in patients with concerning symptoms, with the recognition that a negative test does not exclude the possibility of autoimmune disease (see  <a class="medical medical_review" href="/z/d/html/1822.html" rel="external">"Measurement and clinical significance of antinuclear antibodies"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Imaging studies to rule out asplenia (see  <a class="medical medical_review" href="/z/d/html/7134.html" rel="external">"Splenomegaly and other splenic disorders in adults", section on 'Asplenia or hyposplenia'</a> and  <a class="medical medical_review" href="/z/d/html/7134.html" rel="external">"Splenomegaly and other splenic disorders in adults", section on 'Imaging and biopsy'</a>)</p><p></p><p>The above studies are normal or only mildly abnormal in patients with sIgMD, as shown in the table  (<a class="graphic graphic_table graphicRef80591" href="/z/d/graphic/80591.html" rel="external">table 3</a>). Note that consensus is lacking about the importance of certain laboratory features (ie, vaccine response, T cell numbers and function, and IgG subclasses). (See <a class="local">'Definition'</a> above.)</p><p class="headingAnchor" id="H889929"><span class="h3">Low or absent serum IgM levels</span><span class="headingEndMark"> — </span>The normal serum concentration of IgM for patients &gt;18 years of age is between 37 and 286 mg/dL [<a href="#rid9">9</a>]. Although there are no strict numeric cutoff values for defining IgM deficiency, a level of IgM less than 2 standard deviations from the mean or less than 10 percent from the mean for age, is generally accepted as deficient [<a href="#rid21">21</a>]. Thus, IgM levels less than 10 to 15 mg/dL in infants and children and less than 20 to 30 mg/dL in adults are compatible with IgM deficiency. Immunoglobulin levels should be measured on a least two separate occasions.</p><p class="headingAnchor" id="H890030"><span class="h3">Lymphocyte analysis</span><span class="headingEndMark"> — </span>Numbers of circulating B cells are normal in sIgMD, but an increase of CD21<sup>low</sup> and of IgM memory B cells has been reported [<a href="#rid73">73</a>]. T cell numbers are usually normal, although the count of CD4+ T cells may be low and that of CD8+ cells may be high. For some complicated patients, referral to a specialty center for further study of B lymphocyte biology and function may be indicated  (<a class="graphic graphic_table graphicRef52719" href="/z/d/graphic/52719.html" rel="external">table 4</a>). Flow cytometry to assess lymphocyte subsets is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/3903.html" rel="external">"Laboratory evaluation of the immune system", section on 'Flow cytometry for cell populations'</a>.)</p><p class="headingAnchor" id="H890089"><span class="h3">Vaccine response</span><span class="headingEndMark"> — </span>Specific antibody responses are variable in sIgMD, although they should be assessed to exclude other immunodeficiency disorders and to determine if the patient is a candidate for prophylactic treatment to prevent infections (see <a class="local">'Measures to prevent infections'</a> below) Note that vaccine response is one of the features of sIgMD about which consensus is lacking, with some groups stipulating that it should be normal, but other experts disagreeing. (See <a class="local">'Definition'</a> above.) </p><p class="bulletIndent1"><span class="glyph">●</span>Titers for protective IgG against tetanus and diphtheria can be measured to assess response to protein antigens in vaccinated individuals.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Titers for the serotype-specific IgG to the carbohydrate antigens in the polysaccharide pneumococcal vaccine (usually a commercially available panel of 14 to 23 serotypes) can be measured in children and adults over the age of two years.</p><p></p><p>If titers are low to either tetanus/diphtheria or to pneumococcus and the patient was not vaccinated within the past three to five years, then a dose of an age-appropriate vaccine should be given and titers repeated one month later. The interpretation of a patient's immune response to vaccination is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/3929.html" rel="external">"Assessing antibody function as part of an immunologic evaluation"</a>.)</p><p>Vaccine responses to protein and polysaccharide antigens have not been systematically studied in patients with sIgMD. Case reports and small series suggest that they may be normal or impaired [<a href="#rid24">24,74</a>]. Depressed IgG responses to diphtheria-tetanus were reported in two of six patients with sIgMD in one series, despite normal levels of total IgG [<a href="#rid63">63</a>]. Impaired responses to <a class="drug drug_general" data-topicid="9784" href="/z/d/drug information/9784.html" rel="external">pneumococcal polysaccharide vaccine</a> were reported in five of eight patients in another series [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H889956"><span class="h3">Evaluation of infections</span><span class="headingEndMark"> — </span>For patients presenting with acute infections during the diagnostic evaluation, attempts should be made to document the infection, as well as the responsible organism, whenever possible. This may involve radiologic evaluation for rhinosinusitis and pneumonia, lumbar puncture for meningitis, serologies, and tissue/secretion cultures, as indicated by the clinical presentation.</p><p class="headingAnchor" id="H890366"><span class="h2">Further laboratory evaluation</span><span class="headingEndMark"> — </span>Once an isolated deficiency of serum IgM has been identified, further evaluation may be considered, although these studies are not needed for the diagnosis  (<a class="graphic graphic_table graphicRef52719" href="/z/d/graphic/52719.html" rel="external">table 4</a>). Rather, they are included here to relay what is known about this disorder. Not all of the studies discussed below are readily available, and some are only performed at speciality centers or research laboratories.</p><p class="headingAnchor" id="H890785"><span class="h3">Other antibody studies</span><span class="headingEndMark"> — </span>IgG subclasses may be measured for the purpose of fully assessing the patient's immune system, although the clinical significance of a concomitant IgG subclass deficiency is unclear, as management of IgG subclass deficiency and sIgMD are similar. (See  <a class="medical medical_review" href="/z/d/html/3964.html" rel="external">"IgG subclasses: Physical properties, genetics, and biologic functions"</a> and  <a class="medical medical_review" href="/z/d/html/3920.html" rel="external">"Overview and clinical assessment of the complement system"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Isohemagglutinins, which are comprised of both IgM and IgG, have been variably reported in patients with sIgMD [<a href="#rid13">13,63</a>]. The largest available series reported isohemagglutinins in 33 patients and found a mean titer of anti-A of 1:50±92 and a mean titer of anti-B of 1:12±13 (normal controls were ≥1:64 for both) [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Vaccination with neoantigens may be helpful in uncommon instances where pneumococcal vaccination is either contraindicated (such as an earlier adverse reaction) or ineffective. Neoantigens are only available in some research laboratories.</p><p></p><p class="headingAnchor" id="H22"><span class="h3">Additional lymphocyte testing</span><span class="headingEndMark"> — </span>Immunophenotyping of B cells and in vitro stimulation studies of B and T lymphocytes are commercially available and also performed by specialty centers  (<a class="graphic graphic_table graphicRef52719" href="/z/d/graphic/52719.html" rel="external">table 4</a>). B lymphocytes display normal levels of surface IgM, although this measurement is not commercially available.</p><p class="headingAnchor" id="H890167"><span class="h2">Evaluation for associated conditions</span><span class="headingEndMark"> — </span>Patients with sIgMD should be evaluated for the conditions that have been reported in association with it, if indicated by a careful history and physical examination. In some cases (although not all), the IgM deficiency may be secondary to the other condition and may improve as the primary condition is treated  (<a class="graphic graphic_table graphicRef67168" href="/z/d/graphic/67168.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H24"><span class="h1">DIFFERENTIAL DIAGNOSIS</span></p><p class="headingAnchor" id="H25"><span class="h2">Other immunodeficiencies</span><span class="headingEndMark"> — </span>Subnormal serum levels of IgM (although not <strong>isolated</strong> IgM deficiency) may be seen in other immunodeficiency disorders, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Common variable immunodeficiency (in association with low IgG levels and impaired vaccine response ± low IgA). (See  <a class="medical medical_review" href="/z/d/html/3928.html" rel="external">"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other antibody deficiency syndromes, although other isotypes should be affected as well. (See  <a class="medical medical_review" href="/z/d/html/3914.html" rel="external">"Primary humoral immunodeficiencies: An overview"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Wiskott-Aldrich syndrome (characterized by eczema, thrombocytopenia, and an associated elevation of IgA and IgE). (See  <a class="medical medical_review" href="/z/d/html/3953.html" rel="external">"Wiskott-Aldrich syndrome"</a>.)</p><p></p><p>Similarly, SCID syndromes, which are associated with both cellular and humoral defects, may also demonstrate IgM hypogammaglobulinemia [<a href="#rid75">75</a>]. In all of these conditions, IgM deficiency is accompanied by either abnormal levels of other immunoglobulin classes or by reduced T cell numbers. (See  <a class="medical medical_review" href="/z/d/html/3935.html" rel="external">"Combined immunodeficiencies: An overview"</a> and  <a class="medical medical_review" href="/z/d/html/3955.html" rel="external">"Severe combined immunodeficiency (SCID): An overview"</a>.)</p><p class="headingAnchor" id="H26"><span class="h2">Drug-induced hypogammaglobulinemia</span><span class="headingEndMark"> — </span>Subnormal immunoglobulin levels have been reported with medications, such as antiepileptic medications, gold, and <a class="drug drug_general" data-topicid="9747" href="/z/d/drug information/9747.html" rel="external">d-penicillamine</a>, although IgA deficiency or deficiency of multiple immunoglobulin classes is more typical. <a class="drug drug_general" data-topicid="9289" href="/z/d/drug information/9289.html" rel="external">Clozapine</a> use to treat schizophrenia was associated in one study with a higher than expected, statistically significant occurrence of sIgMD [<a href="#rid76">76</a>]. Causality remains to be determined. (See  <a class="medical medical_review" href="/z/d/html/3914.html" rel="external">"Primary humoral immunodeficiencies: An overview", section on 'Differential diagnosis'</a>.)</p><p class="headingAnchor" id="H27"><span class="h1">TREATMENT AND MONITORING</span><span class="headingEndMark"> — </span>Patients with sIgMD and recurrent infections are managed similarly to individuals with other humoral immune defects, although there are no studies to evaluate the effectiveness of these interventions specifically in patients with sIgMD. Our approach to management is described here.</p><p class="headingAnchor" id="H4746774"><span class="h2">Patient education</span><span class="headingEndMark"> — </span>We explain to patients that information about sIgMD is limited and that although some patients appear to have no specific problems related to the lack of IgM, others are at increased risk for serious infections. We advise patients to seek medical care promptly for fevers or infections that seem to be worsening. We provide them with a letter signed by the evaluating clinician, which states that the patient has sIgMD, a disorder that is sometimes associated with serious infections, such as bacteremia and sepsis. We do this to encourage a thorough evaluation in urgent care and emergency department settings and to increase the likelihood that providers will err on the side of caution when treating these individuals. We counsel patients in this manner, even if they are asymptomatic.</p><p class="headingAnchor" id="H6107180"><span class="h2">Prompt evaluation and treatment of infections</span><span class="headingEndMark"> — </span>If infection is suspected, we evaluate patients promptly, obtain cultures when possible, and have a low threshold for initiating antimicrobials. We follow these individuals closely to assure the infections are fully cleared before terminating treatment. Patients with immunodeficiencies are less likely to clear minor infections without antimicrobials and more likely to require prolonged courses of treatment to eradicate established infections. We provide patients with an informational handout about seeking prompt evaluation for infections  (<a class="graphic graphic_table graphicRef62481" href="/z/d/graphic/62481.html" rel="external">table 5</a>).</p><p class="headingAnchor" id="H6107188"><span class="h2">Measures to prevent infections</span><span class="headingEndMark"> — </span>Measures to prevent recurrent infections include vaccinations, aggressive management of allergic respiratory disease, and in some cases, prophylactic antibiotics or <a class="drug drug_general" data-topicid="16471" href="/z/d/drug information/16471.html" rel="external">immune globulin</a> therapy.</p><p class="bulletIndent1"><span class="glyph">●</span>Patients who respond immunologically to vaccination, even if the response is partial, should be fully vaccinated. We administer <a class="drug drug_general" data-topicid="9784" href="/z/d/drug information/9784.html" rel="external">pneumococcal polysaccharide vaccine</a> during the immune evaluation and administer meningococcal vaccine subsequently if there is adequate polysaccharide responsiveness. (See  <a class="medical medical_review" href="/z/d/html/3901.html" rel="external">"Meningococcal vaccination in children and adults", section on 'Indications and schedules in the United States'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Aggressive management of atopic diseases, such as asthma and allergic rhinitis, may be helpful in reducing the incidence of complicating sinopulmonary infections. (See  <a class="medical medical_review" href="/z/d/html/547.html" rel="external">"An overview of asthma management"</a> and  <a class="medical medical_review" href="/z/d/html/7526.html" rel="external">"Pharmacotherapy of allergic rhinitis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prophylactic antibiotics can be administered to those patients who continue to have frequent infections despite the above measures. Specific regimens are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/3948.html" rel="external">"Inborn errors of immunity (primary immunodeficiencies): Overview of management", section on 'Prophylactic antimicrobial therapy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="16471" href="/z/d/drug information/16471.html" rel="external">Immune globulin</a> contains very little IgM and hence is not advocated as a standard treatment for sIgMD. However, the propensity of patients with sIgMD to get infections is likely not simply related to low serum IgM. Accordingly, one report described five patients with frequent infections, despite preventative measures, who were treated with intravenous immune globulin and had an excellent clinical response [<a href="#rid26">26</a>]. Other case series also support benefit [<a href="#rid77">77</a>]. Consultation with an immunologist is advised. (See  <a class="medical medical_review" href="/z/d/html/3911.html" rel="external">"Immune globulin therapy in inborn errors of immunity"</a>.)</p><p></p><p class="headingAnchor" id="H6107318"><span class="h2">Monitoring</span><span class="headingEndMark"> — </span>We monitor patients for changes in clinical status. New signs or symptoms should be evaluated for evidence of associated conditions. Periodic measurements of IgM, IgG, and IgA may be performed.</p><p class="headingAnchor" id="H19655759"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>In some infants, sIgMD may be transient [<a href="#rid78">78</a>]. In a series of 48 children, 16 were followed for a mean duration of four years, and 87 percent continued to have low levels of IgM, while two also developed low IgA [<a href="#rid23">23</a>]. Beyond this, there is insufficient information to allow generalizations about the prognosis of patients with sIgMD, as the numbers of patients are small, and prospective studies are lacking.</p><p class="headingAnchor" id="H29"><span class="h1">RESOURCES FOR PATIENTS</span><span class="headingEndMark"> — </span>General information for patients with immunodeficiency disorders is available from several sources:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fprimaryimmune.org%2F&amp;token=bL4RqHo8CPPVJDTM0%2BcTmkTM12oVIegmgK8pcWp0TAEePaxWkuUPqswe7oao%2F9D5&amp;TOPIC_ID=3921" target="_blank">Immune Deficiency Foundation</a></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fipopi.org%2F&amp;token=F%2Boix2nYbIED17jy3szEwW6hwa1gQOAuLR6r8ouZO3g%3D&amp;TOPIC_ID=3921" target="_blank">International Patient Organisation for Primary Immunodeficiencies</a></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.nih.gov%2F&amp;token=lblfowwGB6QwC91WNuiIfx%2BStSn7rq9B3zby8gm7%2F8g%3D&amp;TOPIC_ID=3921" target="_blank">National Institutes of Health</a></p><p></p><p class="headingAnchor" id="H4172576514"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/112831.html" rel="external">"Society guideline links: Inborn errors of immunity (previously called primary immunodeficiencies)"</a>.)</p><p class="headingAnchor" id="H30"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition </strong>– Selective immunoglobulin M deficiency (sIgMD) is a rare immune disorder that has been reported in association with bacteremia and other serious infections. There have been fewer than 200 to 300 cases reported. (See <a class="local">'Definition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations </strong>– Patients with immunoglobulin M (IgM) deficiency may be asymptomatic, have repeated infections, and/or present with associated conditions, such as atopic diseases, autoimmune disorders, or malignant and hematologic disorders  (<a class="graphic graphic_table graphicRef67168" href="/z/d/graphic/67168.html" rel="external">table 1</a>). (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reduced serum IgM levels </strong>– IgM deficiency is defined in terms of standard deviations from a population mean, which correlates to levels less than 10 to 15 mg/dL in infants and children and less than 20 to 30 mg/dL in adults. It is essential to measure the IgM level at least twice to confirm the deficiency. (See <a class="local">'Low or absent serum IgM levels'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis </strong>– sIgMD is characterized by deficiency of serum IgM, in association with infection and with normal levels of other immunoglobulin isotypes. Other aspects of the diagnosis, such as vaccine response and T cell findings, are controversial. sIgMD is a diagnosis of exclusion, and other immunologic disorders should be excluded. (See <a class="local">'Evaluation and diagnosis'</a> above and <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management </strong>– Patients with sIgMD and recurrent infections are managed similarly to individuals with other antibody defects and deficiencies, although there are no studies to evaluate the effectiveness of these interventions specifically in patients with sIgMD. (See <a class="local">'Treatment and monitoring'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients who are shown to be either partially or fully vaccine responsive during immune evaluation, we suggest vaccination with pneumococcal and meningococcal vaccines to provide protection against these organisms (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We suggest administration of prophylactic antibiotics to patients who continue to experience recurrent infections (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with impaired vaccine response and severe or refractory recurrent infections despite antibiotic prophylaxis, we suggest <a class="drug drug_general" data-topicid="16471" href="/z/d/drug information/16471.html" rel="external">immune globulin</a> replacement therapy, but this should be guided by consultation with an immunologist (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prognosis </strong>– Information on prognosis is limited. sIgMD may be transient in infants, but, in older children, it appears to be persistent in most. Information on adults is even more limited. (See <a class="local">'Prognosis'</a> above.)</p><p></p><p class="headingAnchor" id="H93123147"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges E Richard Stiehm, MD, who contributed as a Section Editor to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Gupta S, Gupta A. Defining Primary Selective IgM Deficiency. J Clin Immunol 2019; 39:350.</a></li><li><a class="nounderline abstract_t">Stavnezer J, Amemiya CT. Evolution of isotype switching. Semin Immunol 2004; 16:257.</a></li><li><a class="nounderline abstract_t">Diamant E, Melamed D. Class switch recombination in B lymphopoiesis: a potential pathway for B cell autoimmunity. Autoimmun Rev 2004; 3:464.</a></li><li><a class="nounderline abstract_t">Manson JJ, Mauri C, Ehrenstein MR. Natural serum IgM maintains immunological homeostasis and prevents autoimmunity. Springer Semin Immunopathol 2005; 26:425.</a></li><li><a class="nounderline abstract_t">Ehrenstein MR, Cook HT, Neuberger MS. Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J Exp Med 2000; 191:1253.</a></li><li><a class="nounderline abstract_t">Quartier P, Potter PK, Ehrenstein MR, et al. Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro. Eur J Immunol 2005; 35:252.</a></li><li><a class="nounderline abstract_t">Baker N, Ehrenstein MR. Cutting edge: selection of B lymphocyte subsets is regulated by natural IgM. J Immunol 2002; 169:6686.</a></li><li><a class="nounderline abstract_t">GILBERT C, HONG R. QUALITATIVE AND QUANTITATIVE IMMUNOGLOBULIN DEFICIENCY. Am J Med 1964; 37:602.</a></li><li><a class="nounderline abstract_t">Gonzalez-Quintela A, Alende R, Gude F, et al. Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol 2008; 151:42.</a></li><li><a class="nounderline abstract_t">Cassidy JT, Nordby GL. Human serum immunoglobulin concentrations: prevalence of immunoglobulin deficiencies. J Allergy Clin Immunol 1975; 55:35.</a></li><li><a class="nounderline abstract_t">Inoue T, Okumura Y, Shirama M, et al. Selective partial IgM deficiency: functional assessment of T and B lymphocytes in vitro. J Clin Immunol 1986; 6:130.</a></li><li><a class="nounderline abstract_t">Hobbs JR. IgM deficiency. Birth Defects Orig Artic Ser 1975; 11:112.</a></li><li><a class="nounderline abstract_t">Goldstein MF, Goldstein AL, Dunsky EH, et al. Selective IgM immunodeficiency: retrospective analysis of 36 adult patients with review of the literature. Ann Allergy Asthma Immunol 2006; 97:717.</a></li><li><a class="nounderline abstract_t">Janssen LMA, van Hout RWNM, de Vries E, SIMcal Consortium. Challenges in investigating patients with isolated decreased serum IgM: The SIMcal study. Scand J Immunol 2019; 89:e12763.</a></li><li><a class="nounderline abstract_t">Yocum MW, Strong DM, Chusid MJ, Lakin JD. Selective immunoglobulin M (IgM) deficiency in two immunodeficient adults with recurrent staphylococcal pyoderma. Am J Med 1976; 60:486.</a></li><li><a class="nounderline abstract_t">Faulk WP, Kiyasu WS, Cooper MD, Fudenberg HH. Deficiency of IgM. Pediatrics 1971; 47:399.</a></li><li><a class="nounderline abstract_t">Jones DM, Tobin BM, Butterworth A. Three cases of meningococcal infection in a family, associated with a deficient immune response. Arch Dis Child 1973; 48:742.</a></li><li><a class="nounderline abstract_t">Silver HK, Shuster J, Gold P, Freedman SO. Leukopenia, leukoagglutinins, and low IgM in a family with severe febrile illnesses. Clin Immunol Immunopathol 1973; 1:220.</a></li><li><a class="nounderline abstract_t">Caka C, Cimen O, Kahyaoğlu P, et al. Selective IgM deficiency: Follow-up and outcome. Pediatr Allergy Immunol 2021; 32:1327.</a></li><li><a class="nounderline abstract_t">Singh N, Mott SL, Sutamtewagul G, et al. Prevalence and the impact of hypogammaglobulinemia in newly diagnosed chronic lymphocytic lymphoma patients. EJHaem 2020; 1:537.</a></li><li><a class="nounderline abstract_t">Thong YH, Maxwell GM. Primary selective deficiency of immunoglobulin M. Aust N Z J Med 1978; 8:436.</a></li><li><a class="nounderline abstract_t">Kowalczyk D, Szaflarska A. [Primary selective IgM deficiency--forgotten primary immunodeficiency?]. Przegl Lek 2013; 70:1056.</a></li><li><a class="nounderline abstract_t">Castagnoli R, Taietti I, Votto M, et al. Clinical and immunological phenotypes of selective IgM deficiency in children: Results from a multicenter study. Pediatr Allergy Immunol 2023; 34:e14015.</a></li><li><a class="nounderline abstract_t">Hong R, Gupta S. Selective immunoglobulin M deficiency in an adult with Streptococcus pneumoniae sepsis and invasive aspergillosis. J Investig Allergol Clin Immunol 2008; 18:214.</a></li><li><a class="nounderline abstract_t">Ni J, Zhang J, Chen Q, et al. The epidemiology and clinical features of selective immunoglobulin M deficiency: A single-center study in China. J Clin Lab Anal 2020; 34:e23289.</a></li><li><a class="nounderline abstract_t">Yel L, Ramanuja S, Gupta S. Clinical and immunological features in IgM deficiency. Int Arch Allergy Immunol 2009; 150:291.</a></li><li><a class="nounderline abstract_t">Phuphuakrat A, Ngamjanyaporn P, Nantiruj K, et al. Selective IgM deficiency in an adult presenting with Streptococcus pneumoniae septic arthritis. J Microbiol Immunol Infect 2016; 49:150.</a></li><li><a class="nounderline abstract_t">Sugita K, Eguchi M. Chronic idiopathic thrombocytic purpura in a young male patient with isolated IgM deficiency. Int J Hematol 2001; 73:532.</a></li><li><a class="nounderline abstract_t">Kiratli HK, Akar Y. Multiple recurrent hordeola associated with selective IgM deficiency. J AAPOS 2001; 5:60.</a></li><li><a class="nounderline abstract_t">Raziuddin S, Bilal N, Benjamin B. Transient T-cell abnormality in a selective IgM-immunodeficient patient with Brucella infection. Clin Immunol Immunopathol 1988; 46:360.</a></li><li><a class="nounderline abstract_t">Belgemen T, Suskan E, Dogu F, Ikinciogullari A. Selective immunoglobulin M deficiency presenting with recurrent impetigo: a case report and review of the literature. Int Arch Allergy Immunol 2009; 149:283.</a></li><li><a class="nounderline abstract_t">Brilliant LB, Nakano JH, Kitamura T, et al. Occupationally-acquired smallpox in an IgM-deficient health worker. Bull World Health Organ 1981; 59:99.</a></li><li><a class="nounderline abstract_t">Chandra RK, Kaveramma B, Soothill JF. Generalised non-progressive vaccinia associated with IgM deficiency. Lancet 1969; 1:687.</a></li><li><a class="nounderline abstract_t">Mayumi M, Yamaoka K, Tsutsui T, et al. Selective immunoglobulin M deficiency associated with disseminated molluscum contagiosum. Eur J Pediatr 1986; 145:99.</a></li><li><a class="nounderline abstract_t">Iraji F, Faghihi G. Epidermodysplasia verruciformis: association with isolated IgM deficiency and response to treatment with acitretin. Clin Exp Dermatol 2000; 25:41.</a></li><li><a class="nounderline abstract_t">Gul U, Soylu S, Yavuzer R. Epidermodysplasia verruciformis associated with isolated IgM deficiency. Indian J Dermatol Venereol Leprol 2007; 73:420.</a></li><li><a class="nounderline abstract_t">Preneta A, Nada KM, Raja A, Kasubhai M. Chronic Pulmonary Histoplasmosis Identified in a Young Patient with Selective Immunoglobulin M Deficiency. Case Rep Infect Dis 2018; 2018:8740204.</a></li><li><a class="nounderline abstract_t">Hassanein HA, Elbadry MI. Selective immunoglobulin M deficiency in an adult with miliary tuberculosis: A clinically interesting coexistence. A case report and review of the literature. Int J Mycobacteriol 2016; 5:106.</a></li><li><a class="nounderline abstract_t">Gharib A, Louis AG, Agrawal S, Gupta S. Syndrome of selective IgM deficiency with severe T cell deficiency associated with disseminated cutaneous mycobacterium avium intracellulaire infection. Am J Clin Exp Immunol 2015; 4:15.</a></li><li><a class="nounderline abstract_t">Narsai T, Su H, Braxton D, Gupta S. Collagenous Gastritis in Primary Selective IgM Deficiency: Transition to EBV+ Gastric Adenocarcinoma. Case Reports Immunol 2021; 2021:5574944.</a></li><li><a class="nounderline abstract_t">Vogelzang NJ, Corwin H, Finlay JL, et al. Clear cell sarcoma and selective IgM deficiency: a case report. Cancer 1982; 49:234.</a></li><li><a class="nounderline abstract_t">Kondo N, Ozawa T, Kato Y, et al. Reduced secreted mu mRNA synthesis in selective IgM deficiency of Bloom's syndrome. Clin Exp Immunol 1992; 88:35.</a></li><li><a class="nounderline abstract_t">Takenaka T, Nakamine H, Nishihara T, et al. Prolymphocytic leukemia with IgM hypogammaglobulinemia. Am J Clin Pathol 1983; 80:237.</a></li><li><a class="nounderline abstract_t">Ozawa T, Kondo N, Motoyoshi F, et al. Preferential damage to IgM production by ultraviolet B in the cells of patients with Bloom's syndrome. Scand J Immunol 1993; 38:225.</a></li><li><a class="nounderline abstract_t">Saini S, Dettore AJ, Bhambhani KJ, et al. Selective IgM deficiency in CD30+ cutaneous lymphoproliferative disorder. J Pediatr Hematol Oncol 2011; 33:e156.</a></li><li><a class="nounderline abstract_t">Karakantza M, Mouzaki A, Theodoropoulou M, et al. Th1 and Th2 cytokines in a patient with Evans' syndrome and profound lymphopenia. Br J Haematol 2000; 110:968.</a></li><li><a class="nounderline abstract_t">Arahata M, Tajiri K, Nomoto K, et al. A novel type of selective immunoglobulin m deficiency in a patient with autoimmune liver cirrhosis with recurrent hepatocellular carcinoma: a case report and review of the literature. Int Arch Allergy Immunol 2013; 161:91.</a></li><li><a class="nounderline abstract_t">Shimamura Y, Maeda T, Abe K, et al. Selective immunoglobulin M deficiency complicated by systemic lupus erythematosus and antiphospholipid syndrome: a case report and review of literature. CEN Case Rep 2021; 10:435.</a></li><li><a class="nounderline abstract_t">Saiki O, Saeki Y, Tanaka T, et al. Development of selective IgM deficiency in systemic lupus erythematosus patients with disease of long duration. Arthritis Rheum 1987; 30:1289.</a></li><li><a class="nounderline abstract_t">Takeuchi T, Nakagawa T, Maeda Y, et al. Functional defect of B lymphocytes in a patient with selective IgM deficiency associated with systemic lupus erythematosus. Autoimmunity 2001; 34:115.</a></li><li><a class="nounderline abstract_t">Kimura S, Tanigawa M, Nakahashi Y, et al. Selective IgM deficiency in a patient with Hashimoto's disease. Intern Med 1993; 32:302.</a></li><li><a class="nounderline abstract_t">Antar M, Lamarche J, Peguero A, et al. A case of selective immunoglobulin M deficiency and autoimmune glomerulonephritis. Clin Exp Nephrol 2008; 12:300.</a></li><li><a class="nounderline abstract_t">Sano A, Inoue J, Kakazu E, et al. Acute-onset Autoimmune Hepatitis in a Patient with Selective Immunoglobulin M Deficiency. Intern Med 2019; 58:2185.</a></li><li><a class="nounderline abstract_t">Oh J, McGarry D, Peppers B, Hostoffer R. Selective IgM deficiency associated with adult-onset Still disease. Ann Allergy Asthma Immunol 2018; 120:444.</a></li><li><a class="nounderline abstract_t">Morita M, Saibara T, Nakazawa Y, et al. [A case of Crohn's disease associated with selective IgM deficiency]. Nihon Shokakibyo Gakkai Zasshi 1984; 81:1070.</a></li><li><a class="nounderline abstract_t">Popa V, Colby TV, Reich SB. Pulmonary interstitial disease in Ig deficiency. Chest 2002; 122:1594.</a></li><li><a class="nounderline abstract_t">Bedu-Addo G, Sheldon J, Bates I. Massive splenomegaly in tropical West Africa. Postgrad Med J 2000; 76:107.</a></li><li><a class="nounderline abstract_t">Fallon KE. Inability to train, recurrent infection, and selective IgM deficiency. Clin J Sport Med 2004; 14:357.</a></li><li><a class="nounderline abstract_t">Makay B, Unsal E, Anal O, et al. Chronic recurrent multifocal osteomyelitis in a patient with selective immunoglobulin M deficiency. Rheumatol Int 2009; 29:811.</a></li><li><a class="nounderline abstract_t">Giorgio F, Principi M, Losurdo G, et al. Seronegative Celiac Disease and Immunoglobulin Deficiency: Where to Look in the Submerged Iceberg? Nutrients 2015; 7:7486.</a></li><li><a class="nounderline abstract_t">Montenegro L, Piscitelli D, Giorgio F, et al. Reversal of IgM deficiency following a gluten-free diet in seronegative celiac disease. World J Gastroenterol 2014; 20:17686.</a></li><li><a class="nounderline abstract_t">Ross IN, Thompson RA. Severe selective IgM deficiency. J Clin Pathol 1976; 29:773.</a></li><li><a class="nounderline abstract_t">Guill MF, Brown DA, Ochs HD, et al. IgM deficiency: clinical spectrum and immunologic assessment. Ann Allergy 1989; 62:547.</a></li><li><a class="nounderline abstract_t">Hobbs JR. Immunoflobulins and malabsorption. Proc R Soc Med 1969; 62:982.</a></li><li><a class="nounderline abstract_t">Ohno T, Inaba M, Kuribayashi K, et al. Selective IgM deficiency in adults: phenotypically and functionally altered profiles of peripheral blood lymphocytes. Clin Exp Immunol 1987; 68:630.</a></li><li><a class="nounderline abstract_t">Yamasaki T. Selective IgM deficiency: functional assessment of peripheral blood lymphocytes in vitro. Intern Med 1992; 31:866.</a></li><li><a class="nounderline abstract_t">Boes M, Schmidt T, Linkemann K, et al. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci U S A 2000; 97:1184.</a></li><li><a class="nounderline abstract_t">Cipe FE, Doğu F, Güloğlu D, et al. B-cell subsets in patients with transient hypogammaglobulinemia of infancy, partial IgA deficiency, and selective IgM deficiency. J Investig Allergol Clin Immunol 2013; 23:94.</a></li><li><a class="nounderline abstract_t">Moffitt JE, Guill MF, Wray BB, et al. Effect of interleukin-2 and mitogen on in vitro immunoglobulin production by peripheral blood lymphocytes from patients with selective IgM deficiency. Ann Allergy 1988; 61:424.</a></li><li><a class="nounderline abstract_t">De la Concha EG, Garcia-Rodriguez MC, Zabay JM, et al. Functional assessment of T and B lymphocytes in patients with selective IgM deficiency. Clin Exp Immunol 1982; 49:670.</a></li><li><a class="nounderline abstract_t">Al-Herz W, McGeady SJ, Gripp KW. 22q11.2 deletion syndrome and selective IgM deficiency: an association of a common chromosomal abnormality with a rare immunodeficiency. Am J Med Genet A 2004; 127A:99.</a></li><li><a class="nounderline abstract_t">Kung SJ, Gripp KW, Stephan MJ, et al. Selective IgM deficiency and 22q11.2 deletion syndrome. Ann Allergy Asthma Immunol 2007; 99:87.</a></li><li><a class="nounderline abstract_t">Louis AG, Agrawal S, Gupta S. Analysis of subsets of B cells, Breg, CD4Treg and CD8Treg cells in adult patients with primary selective IgM deficiency. Am J Clin Exp Immunol 2016; 5:21.</a></li><li><a class="nounderline abstract_t">Goldstein MF, Goldstein AL, Dunsky EH, et al. Pediatric selective IgM immunodeficiency. Clin Dev Immunol 2008; 2008:624850.</a></li><li><a class="nounderline abstract_t">Fischer A. Human primary immunodeficiency diseases: a perspective. Nat Immunol 2004; 5:23.</a></li><li><a class="nounderline abstract_t">Lozano R, Marin R, Santacruz MJ, Pascual A. Selective Immunoglobulin M Deficiency Among Clozapine-Treated Patients: A Nested Case-Control Study. Prim Care Companion CNS Disord 2015; 17.</a></li><li><a class="nounderline abstract_t">Goldstein MF, Hilditch GJ, Dvorin DJ, Belecanech GA. Immunoglobulin replacement for selective IgM immunodeficiency, bronchiectasis, and asthma. Ann Allergy Asthma Immunol 2016; 116:172.</a></li><li><a class="nounderline abstract_t">Ozen A, Baris S, Karakoc-Aydiner E, et al. Outcome of hypogammaglobulinemia in children: immunoglobulin levels as predictors. Clin Immunol 2010; 137:374.</a></li></ol></div><div id="topicVersionRevision">Topic 3921 Version 29.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31073845" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Defining Primary Selective IgM Deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15522624" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Evolution of isotype switching.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15351312" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Class switch recombination in B lymphopoiesis: a potential pathway for B cell autoimmunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15611856" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Natural serum IgM maintains immunological homeostasis and prevents autoimmunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10748243" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15597324" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12471099" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Cutting edge: selection of B lymphocyte subsets is regulated by natural IgM.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14215847" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : QUALITATIVE AND QUANTITATIVE IMMUNOGLOBULIN DEFICIENCY.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18005364" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/803275" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Human serum immunoglobulin concentrations: prevalence of immunoglobulin deficiencies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2872228" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Selective partial IgM deficiency: functional assessment of T and B lymphocytes in vitro.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/50091" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : IgM deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17201230" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Selective IgM immunodeficiency: retrospective analysis of 36 adult patients with review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30887554" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Challenges in investigating patients with isolated decreased serum IgM: The SIMcal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1274982" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Selective immunoglobulin M (IgM) deficiency in two immunodeficient adults with recurrent staphylococcal pyoderma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5542782" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Deficiency of IgM.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4733645" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Three cases of meningococcal infection in a family, associated with a deficient immune response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4357797" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Leukopenia, leukoagglutinins, and low IgM in a family with severe febrile illnesses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33706406" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Selective IgM deficiency: Follow-up and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35845010" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Prevalence and the impact of hypogammaglobulinemia in newly diagnosed chronic lymphocytic lymphoma patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/367347" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Primary selective deficiency of immunoglobulin M.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24720127" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : [Primary selective IgM deficiency--forgotten primary immunodeficiency?].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37728524" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Clinical and immunological phenotypes of selective IgM deficiency in children: Results from a multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18564634" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Selective immunoglobulin M deficiency in an adult with Streptococcus pneumoniae sepsis and invasive aspergillosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32157736" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The epidemiology and clinical features of selective immunoglobulin M deficiency: A single-center study in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19494527" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Clinical and immunological features in IgM deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23523054" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Selective IgM deficiency in an adult presenting with Streptococcus pneumoniae septic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11503970" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Chronic idiopathic thrombocytic purpura in a young male patient with isolated IgM deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11182678" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Multiple recurrent hordeola associated with selective IgM deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2962796" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Transient T-cell abnormality in a selective IgM-immunodeficient patient with Brucella infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19218822" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Selective immunoglobulin M deficiency presenting with recurrent impetigo: a case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7020974" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Occupationally-acquired smallpox in an IgM-deficient health worker.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4182649" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Generalised non-progressive vaccinia associated with IgM deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3089801" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Selective immunoglobulin M deficiency associated with disseminated molluscum contagiosum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10671971" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Epidermodysplasia verruciformis: association with isolated IgM deficiency and response to treatment with acitretin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18032865" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Epidermodysplasia verruciformis associated with isolated IgM deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29888016" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Chronic Pulmonary Histoplasmosis Identified in a Young Patient with Selective Immunoglobulin M Deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26928000" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Selective immunoglobulin M deficiency in an adult with miliary tuberculosis: A clinically interesting coexistence. A case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26550546" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Syndrome of selective IgM deficiency with severe T cell deficiency associated with disseminated cutaneous mycobacterium avium intracellulaire infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34123443" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Collagenous Gastritis in Primary Selective IgM Deficiency: Transition to EBV+ Gastric Adenocarcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7053825" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Clear cell sarcoma and selective IgM deficiency: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1563106" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Reduced secreted mu mRNA synthesis in selective IgM deficiency of Bloom's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6603786" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Prolymphocytic leukemia with IgM hypogammaglobulinemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8356398" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Preferential damage to IgM production by ultraviolet B in the cells of patients with Bloom's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21516014" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Selective IgM deficiency in CD30+ cutaneous lymphoproliferative disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11054090" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Th1 and Th2 cytokines in a patient with Evans' syndrome and profound lymphopenia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23257944" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : A novel type of selective immunoglobulin m deficiency in a patient with autoimmune liver cirrhosis with recurrent hepatocellular carcinoma: a case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33616883" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Selective immunoglobulin M deficiency complicated by systemic lupus erythematosus and antiphospholipid syndrome: a case report and review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3689463" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Development of selective IgM deficiency in systemic lupus erythematosus patients with disease of long duration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11905841" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Functional defect of B lymphocytes in a patient with selective IgM deficiency associated with systemic lupus erythematosus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8358120" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Selective IgM deficiency in a patient with Hashimoto's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18365138" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : A case of selective immunoglobulin M deficiency and autoimmune glomerulonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30996186" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Acute-onset Autoimmune Hepatitis in a Patient with Selective Immunoglobulin M Deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29625671" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Selective IgM deficiency associated with adult-onset Still disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6748317" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : [A case of Crohn's disease associated with selective IgM deficiency].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12426258" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Pulmonary interstitial disease in Ig deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10644392" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Massive splenomegaly in tropical West Africa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15523208" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Inability to train, recurrent infection, and selective IgM deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19034453" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Chronic recurrent multifocal osteomyelitis in a patient with selective immunoglobulin M deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26371035" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Seronegative Celiac Disease and Immunoglobulin Deficiency: Where to Look in the Submerged Iceberg?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25516687" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Reversal of IgM deficiency following a gluten-free diet in seronegative celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/977778" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Severe selective IgM deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2735562" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : IgM deficiency: clinical spectrum and immunologic assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4186666" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Immunoflobulins and malabsorption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2958191" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Selective IgM deficiency in adults: phenotypically and functionally altered profiles of peripheral blood lymphocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1450494" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Selective IgM deficiency: functional assessment of peripheral blood lymphocytes in vitro.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10655505" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23654075" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : B-cell subsets in patients with transient hypogammaglobulinemia of infancy, partial IgA deficiency, and selective IgM deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3059849" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Effect of interleukin-2 and mitogen on in vitro immunoglobulin production by peripheral blood lymphocytes from patients with selective IgM deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6983403" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Functional assessment of T and B lymphocytes in patients with selective IgM deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15103727" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : 22q11.2 deletion syndrome and selective IgM deficiency: an association of a common chromosomal abnormality with a rare immunodeficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17650836" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Selective IgM deficiency and 22q11.2 deletion syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27168952" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Analysis of subsets of B cells, Breg, CD4Treg and CD8Treg cells in adult patients with primary selective IgM deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19043622" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Pediatric selective IgM immunodeficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14699405" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Human primary immunodeficiency diseases: a perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26693046" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Selective Immunoglobulin M Deficiency Among Clozapine-Treated Patients: A Nested Case-Control Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26712522" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Immunoglobulin replacement for selective IgM immunodeficiency, bronchiectasis, and asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20851686" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Outcome of hypogammaglobulinemia in children: immunoglobulin levels as predictors.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
